Application of pediatric and adult guidelines for treatment of lipid levels among US adolescents transitioning to young adulthood

JAMA Pediatrics

Volumn 169, Issue 6, 2015, Pages 569-574

  Gooding, Holly C ^a   Rodday, Angie Mae ^b   Wong, John B ^b   Gillman, Matthew W ^c   Lloyd Jones, Donald M ^d   Leslie, Laurel K ^b   De Ferranti, Sarah D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING; UNITED STATES; AGE; ALGORITHM; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; DOSE RESPONSE; HYPERCHOLESTEROLEMIA; NUTRITION; RISK FACTOR; TRANSITION TO ADULT CARE; UTILIZATION; UTILIZATION REVIEW; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; ALGORITHMS; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; NUTRITION SURVEYS; RISK FACTORS; TRANSITION TO ADULT CARE; UNITED STATES; UTILIZATION REVIEW; YOUNG ADULT;

EID: 84930808654     PISSN: 21686203     EISSN: 21686211     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.0168     Document Type: Article

References (19)

1. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591-600.
2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
3. Stone NJ, Robinson JG, Lichtenstein AH, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25)(suppl 2):S1-S45.
4. Gillman MW, Daniels SR. Is universal pediatric lipid screening justified? JAMA. 2012;307(3):259-260.
5. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382(9907):1762-1765.
6. McCrindle BW, Tyrrell PN, Kavey RE. Will obesity increase the proportion of children and adolescents recommended for a statin? Circulation. 2013;128(19):2162-2165.
7. Pencina MJ, Navar-Boggan AM, D'Agostino RB Sr, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370(15):1422-1431.
8. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2014. http://www.cdc.gov/nchs/nhanes/.htm. Accessed January 15, 2015.
9. Doran B, Guo Y, Xu J, et al. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014;130(7):546-553.
10. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206-213.
11. Johnson CL, Paulose-Ram R, Ogden CL, et al. National Health and Nutrition Examination Survey: analytic guidelines, 1999-2010. Vital Health Stat 2. 2013;2(161):1-24.
12. Centers for Disease Control and Prevention (CDC). National Biomonitoring Program. Summary: cotinine. 2013; http://www.cdc.gov/biomonitoring/Cotinine-BiomonitoringSummary.html. Accessed August 5, 2014.
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106(25):3143-3421.
14. Taylor FC, Huffman M, Ebrahim S. Statin therapy for primary prevention of cardiovascular disease. JAMA. 2013;310(22):2451-2452.
15. Holmes MV, Asselbergs FW, Palmer TM, et al; UCLEB consortium. Mendelian randomization of blood lipids for coronary heart disease [published online January 27, 2014]. Eur Heart J. 2014. doi:10.1093/eurheartj/eht571.
16. Juonala M, Magnussen CG, Venn A, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122(24):2514-2520.
17. Vinci SR, Rifas-Shiman SL, Cheng JK, Mannix RC, Gillman MW, de Ferranti SD. Cholesterol testing among children and adolescents during health visits. JAMA. 2014;311(17):1804-1807.
18. McGrady ME, Hommel KA. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics. 2013;132(4):730-740.
19. Barry MJ, Edgman-Levitan S. Shared decision making: pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780-781.